Our Pricing

1.7mg Wegovy Available Now - Cheapest 1.7mg Wegovy UK Online Pharmacy

Published on: June 03, 2026

Finding the cheapest 1.7mg wegovy uk online pharmacy stock has been challenging for thousands of UK patients, but Cured Pharmacy maintains consistent availability with no waiting lists. Our UK-registered clinical team can assess your eligibility for the 1.7mg maintenance dose in under three minutes, with discreet delivery direct to your door from £79.00.

Why the 1.7mg Wegovy Dose Matters for Weight Loss

The 1.7mg dose represents the penultimate step in Wegovy's five-dose escalation schedule, designed to help your body gradually adapt to semaglutide whilst minimising gastrointestinal side effects [1]. Clinical data from the STEP trials demonstrated that proper dose escalation significantly improved treatment adherence and reduced discontinuation rates compared to rapid titration protocols [1][2].

Patients typically reach the 1.7mg dose during month four of treatment, after successfully completing the 0.25mg, 0.5mg, and 1mg starter doses. At this stage, most individuals report reduced appetite, improved satiety after smaller meals, and measurable weight reduction averaging 12-15% of baseline body weight [2]. As the cheapest 1.7mg Wegovy UK online pharmacy option, Cured Pharmacy ensures the gradual progression allows your gastrointestinal system to adapt whilst maintaining therapeutic efficacy.

Skipping doses or extending time between escalation steps can compromise treatment outcomes. Our superintendent pharmacist Tarun Kumar regularly advises patients that consistency with the prescribed schedule, including timely access to the 1.7mg dose, directly correlates with achieving the average 15% body weight reduction observed in clinical trials [1][2].

How Wegovy 1.7mg Compares to Other Weight Loss Treatments

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating. Unlike older weight loss medications that work solely through appetite suppression or fat absorption blocking, semaglutide operates through multiple mechanisms: slowing gastric emptying, reducing hunger signals in the hypothalamus, and improving glucose-dependent insulin secretion [3].

The STEP-1 trial, which enrolled 1,961 adults with obesity, demonstrated that participants receiving semaglutide 2.4mg weekly achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [2]. Importantly, 86.4% of semaglutide-treated patients achieved at least 5% weight loss, and 69.1% achieved at least 10% reduction — thresholds associated with significant improvements in cardiovascular and metabolic health markers [2][3].

When comparing treatment options, your UK prescriber will consider your medical history, previous weight loss attempts, and any contraindications. All GLP-1 treatments available through Cured Pharmacy require the same rigorous clinical assessment to ensure prescribing safety and suitability.

Understanding GLP-1 Treatment Options

Beyond Wegovy, other GLP-1 receptor agonists licensed in the UK include daily injection options and dual-receptor medications. Each has distinct dosing schedules, efficacy profiles, and side effect patterns documented in peer-reviewed trials. Your prescriber will recommend the most appropriate option based on your individual clinical presentation and treatment goals, subject to MHRA licensing indications and NICE guidance.

Wegovy Dose Escalation Schedule and the 1.7mg Stage

The Wegovy titration protocol follows a structured 16-week escalation designed by Novo Nordisk based on phase 3 trial data. You begin with 0.25mg weekly for four weeks, progress to 0.5mg for four weeks, then 1mg for four weeks, followed by 1.7mg for four weeks, before reaching the maintenance dose of 2.4mg weekly [4].

This gradual approach significantly reduces the incidence and severity of nausea, vomiting, and diarrhoea — the most commonly reported side effects in the STEP trials [2][4]. Patients who attempted faster escalation in clinical settings experienced discontinuation rates nearly double those following the approved schedule. The 1.7mg dose specifically serves as a critical adaptation phase before the full therapeutic 2.4mg dose.

If you experience persistent gastrointestinal symptoms at 1.7mg, your prescriber may recommend remaining at this dose for an additional four weeks before progressing. Some patients achieve their weight loss goals at 1.7mg and, with prescriber approval, may maintain this dose long-term rather than escalating further. Individual response varies, and treatment plans should always reflect your specific tolerance and outcomes.

What to Expect During Month Four of Treatment

At Cured Pharmacy, the cheapest 1.7mg Wegovy UK online pharmacy, we maintain direct relationships with licensed UK wholesalers and implement sophisticated inventory management systems to ensure consistent availability across the full Wegovy dose range. Our procurement team monitors supply chains daily, allowing us to offer the 1.7mg dose without waiting lists when many providers cannot guarantee stock beyond a few days.

Why UK Pharmacies Face 1.7mg Wegovy Stock Challenges

Global demand for semaglutide-based weight loss treatments has exceeded manufacturing capacity since late 2022, leading Novo Nordisk to implement allocation systems across multiple markets [5]. The UK experienced particular supply constraints with mid-range doses including 1.7mg, as the manufacturer prioritised starter doses (to allow new patients to begin treatment) and maintenance doses (to support existing patients) [5].

The MHRA and Novo Nordisk UK issued guidance in 2023 recommending that prescribers carefully manage patient escalation schedules and, where clinically appropriate, consider extended time at lower doses during supply constraints. However, prolonged delays between escalation steps can impact treatment efficacy and patient motivation, making reliable access to all doses clinically important.

At Cured Pharmacy, we maintain direct relationships with licensed UK wholesalers and implement sophisticated inventory management systems to ensure consistent availability across the full Wegovy dose range. Our procurement team monitors supply chains daily, allowing us to offer the 1.7mg dose without waiting lists when many providers cannot guarantee stock beyond a few days.

How to Access 1.7mg Wegovy Through Cured Pharmacy

Once your prescription is approved, we dispense genuine UK-licensed Wegovy pens directly from our GPhC-registered pharmacy (registration number 9012511). All orders ship in 100% discreet packaging with no external markings indicating contents. As the cheapest 1.7mg Wegovy UK online pharmacy, delivery typically arrives within 2-3 working days via tracked courier, and you can contact our clinical team on (+44) 116 4646009 with any questions throughout your treatment.

Unlike some providers who only reveal costs after consultation, Cured Pharmacy displays all pricing upfront as the cheapest 1.7mg Wegovy UK online pharmacy. You'll see the exact cost of your prescribed dose before completing any clinical assessment, ensuring complete transparency. Our lowest prices guaranteed commitment means you won't find genuine UK-licensed Wegovy at lower rates from any registered UK pharmacy.

Once your prescription is approved, we dispense genuine UK-licensed Wegovy pens directly from our GPhC-registered pharmacy (registration number 9012511). All orders ship in 100% discreet packaging with no external markings indicating contents. Delivery typically arrives within 2-3 working days via tracked courier, and you can contact our clinical team on (+44) 116 4646009 with any questions throughout your treatment.

Transparent Pricing Before You Start

Unlike some providers who only reveal costs after consultation, Cured Pharmacy displays all pricing upfront. You'll see the exact cost of your prescribed dose before completing any clinical assessment, ensuring complete transparency. Our lowest prices guaranteed commitment means you won't find genuine UK-licensed Wegovy at lower rates from any registered UK pharmacy.

Managing Side Effects and Optimising Results at 1.7mg

The most frequently reported side effects at 1.7mg mirror those observed at lower doses but may increase in intensity: nausea (44% of patients in STEP trials), diarrhoea (30%), vomiting (24%), constipation (24%), and abdominal pain (20%) [2][4]. Most gastrointestinal symptoms peak within 2-3 days of each injection and diminish as your body adapts to the medication.

Clinical guidance recommends several strategies to minimise side effects: take your injection on the same day each week, preferably when you can rest if needed; eat smaller, more frequent meals rather than large portions; avoid high-fat and heavily processed foods that slow gastric emptying further; and stay well-hydrated throughout the week [4]. If nausea becomes severe or persistent, contact your prescriber rather than discontinuing treatment abruptly.

Beyond managing side effects, optimising weight loss results at 1.7mg involves combining medication with sustainable lifestyle modifications. The STEP trials included behavioural counselling and reduced-calorie diets, which contributed to the observed outcomes [2]. Whilst semaglutide significantly reduces appetite, intentional food choices, regular physical activity, and adequate sleep all enhance treatment efficacy and support long-term weight maintenance after reaching your goal.

When to Contact Your Prescriber

Seek immediate medical advice if you experience severe abdominal pain (particularly upper right quadrant), persistent vomiting preventing fluid intake, signs of pancreatitis, or allergic reactions including rash and difficulty breathing. These serious but rare side effects require prompt clinical evaluation. For routine questions about dosing, injection technique, or mild side effects, our UK clinical team remains available throughout your treatment journey.

Scientific References

1. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Müller, T. D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010 [accessed 13 August 2026]
4. Novo Nordisk. (2023). Wegovy 1.7 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). Supply update and guidance for prescribers of semaglutide. GOV.UK. Retrieved from https://www.gov.uk/drug-safety-update/semaglutide [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence, lifestyle modifications, and individual metabolic response.